High-purity GHK-Cu 100mg is available for laboratory research applications through PX1 Research. Synthesized in GMP-compliant, USA-based facilities, each lot undergoes rigorous HPLC and mass spectrometry testing to guarantee ≥98% purity alongside lot-specific endotoxin analysis for reliable cell culture and molecular assays.
High-purity GHK-Cu 100mg is available for laboratory research applications through PX1 Research. Synthesized in GMP-compliant, USA-based facilities, each lot undergoes rigorous HPLC and mass spectrometry testing to guarantee ≥98% purity alongside lot-specific endotoxin analysis for reliable cell culture and molecular assays.
Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu) is a naturally occurring tripeptide-copper complex first isolated from human plasma in 1973. It consists of the amino acid sequence L-glycyl-L-histidyl-L-lysine bound to a divalent copper ion (Cu2+). In biological systems, the peptide exhibits a remarkably high affinity for copper(II), forming a stable coordination complex that modulates cellular copper uptake and enzymatic activity.
Researchers seeking to buy GHK-Cu 100mg for in vitro and preclinical models utilize this compound to evaluate metallopeptide biochemistry. The presence of the copper center allows GHK-Cu to participate in redox balance, gene regulation, and extracellular matrix (ECM) signaling pathways. When sourcing compounds from our all peptides catalog, investigators receive analytical-grade material engineered specifically for rigorous quantitative protocols.
Preclinical investigations demonstrate that GHK-Cu acts as a signal peptide capable of regulating thousands of human genes. At the molecular level, the tripeptide complex alters expression profiles associated with cellular remodeling, tissue repair, and antioxidant defense. Studies indicate that GHK-Cu downregulates pro-inflammatory cytokines such as TNF-alpha and IL-6 while upregulating anti-inflammatory factors in cultured fibroblast models.
In cell culture assays, GHK-Cu interacts with cell surface receptors and intracellular transport proteins to regulate copper homeostasis. By controlling local copper delivery, the complex serves as an essential cofactor for superoxide dismutase (SOD1) and lysyl oxidase (LOX). These enzymatic cascades play central roles in scavenging reactive oxygen species (ROS) and facilitating protein cross-linking within the extracellular framework.
A primary focus of GHK-Cu research involves its capacity to stimulate extracellular matrix deposition. In vitro studies using human dermal fibroblasts demonstrate that exposure to GHK-Cu significantly increases mRNA expression and protein levels of Type I and Type III collagen. This upregulation occurs alongside an increase in elastin production, providing a balanced structural matrix in cell culture environments.
In addition to structural proteins, GHK-Cu regulates the synthesis of glycosaminoglycans (GAGs), such as decorin and hyaluronic acid. Preclinical data suggest that GHK-Cu exerts a selective regulatory effect: it promotes matrix production when structural degradation is present, while simultaneously activating matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) to prevent excessive accumulation. To review detailed biochemical pathways, researchers can examine our comprehensive GHK-Cu research guide.
In animal models of dermal injury, GHK-Cu accelerated wound closure by enhancing chemoattraction for macrophages, mast cells, and capillary endothelial cells to the site of injury. Rodent studies indicate that local application of GHK-Cu speeds up re-epithelialization, increases granulation tissue formation, and elevates local angiogenesis during early repair phases.
Crucially, GHK-Cu exhibits anti-fibrotic properties in preclinical models of wound healing. Rather than inducing uncontrolled connective tissue buildup, the peptide regulates the equilibrium between MMP-1, MMP-2, and TIMP-1. This controlled remodeling mechanism helps prevent aberrant collagen deposition, making GHK-Cu a key target in investigations aiming to minimize fibrotic scarring and hypertrophic tissue formation. Researchers can further explore tissue repair dynamics in our expanded research library.
When evaluating matrix-modifying research peptides, laboratory investigators frequently compare GHK-Cu to other structural and regulatory peptides. While GHK-Cu functions via copper-dependent enzymatic pathways and broad gene transcription, Matrixyl (Pal-KTTKS) acts specifically as a matrikine signal peptide that targets pro-collagen synthesis without direct metal ion coordination.
Conversely, compounds like Epithalon 10mg operate through distinct telomerase-activating and pineal-regulatory mechanisms focused on cellular senescence rather than direct ECM remodeling. Furthermore, when evaluating systemic tissue recovery models, researchers often contrast GHK-Cu with cytoprotective peptides like BPC-157. Understanding these mechanistic differences allows laboratories to design controlled comparative studies across diverse physiological pathways.
PX1 Research supplies GHK-Cu as a lyophilized blue cake or powder containing 100mg of active tripeptide complex. Because GHK-Cu is highly water-soluble, reconstitution for laboratory protocols should be performed under aseptic conditions within a laminar flow hood using sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4).
To preserve the integrity of the peptide-metal coordination complex, researchers should avoid strong chelating agents (such as EDTA) or highly acidic solvents in the reconstitution media. Once dissolved, gentle swirling is recommended; vigorous vortexing should be minimized to prevent shear stress on the peptide backbone. Reconstituted stock solutions should be aliquoted into single-use polypropylene tubes to prevent repeat freeze-thaw cycles.
Lyophilized GHK-Cu 100mg vials remain stable when stored at -20°C or -80°C in a desiccated environment away from light exposure. Under these frozen conditions, the dry peptide retains full analytical potency for up to 24 months. Short-term ambient exposure during transport does not degrade the compound due to its stable lyophilized matrix.
Following reconstitution, liquid stock solutions stored at 4°C are stable for up to 30 days. For long-term liquid storage, aliquots stored at -80°C maintain structural stability for up to 6 months. Researchers requiring large-scale, ongoing studies can coordinate institutional orders via our dedicated wholesale lab platform to ensure consistent batch availability.
PX1 Research maintains rigorous quality control protocols across all research compounds. Every lot of GHK-Cu 100mg undergoes reverse-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity standards (≥98%). Electrospray ionization mass spectrometry (ESI-MS) confirms exact molecular weight and structural identity, ensuring the precise 1:1 stoichiometry of the peptide to copper ion.
Because cellular assays and culture media are highly sensitive to bacterial contaminants, all PX1 Research lots undergo quantitative Chromogenic LAL endotoxin testing. Our products are manufactured in ISO 17025 accredited and GMP-compliant facilities within the USA. Each shipment includes a lot-specific Certificate of Analysis (COA) directly verifiable by laboratory personnel.
PX1 Research is an established USA supplier dedicated exclusively to supporting academic, biotechnology, and institutional research laboratories. We operate fulfillment centers in California and Arizona, enabling same-day dispatch for orders placed before 3:00 PM PST, Monday through Friday.
By prioritizing batch traceability, transparent analytical documentation, and reliable shipping, PX1 Research provides the research community with dependable reagents. All compounds are offered strictly for in vitro, analytical, and preclinical research applications.
What is the purity standard for GHK-Cu 100mg from PX1 Research?
Every lot of GHK-Cu 100mg is verified by RP-HPLC to meet or exceed 98.0% peptide purity. Analytical reports accompany every order.
Is GHK-Cu 100mg approved for human use or cosmetic application?
No. GHK-Cu 100mg is sold strictly as a laboratory research compound for in vitro, cell culture, and preclinical testing. It is not intended for human consumption, topical application, or medical administration.
What documentation is provided with the compound?
Each lot comes with a downloadable, lot-specific Certificate of Analysis (COA) featuring RP-HPLC chromatograms, Mass Spectrometry (MS) identity verification, and LAL endotoxin test results.
How should lyophilized GHK-Cu 100mg be stored upon arrival?
Lyophilized vials should be stored at -20°C or -80°C in a dry, dark environment. Reconstituted stock solutions should be kept at 4°C for short-term use or -80°C for long-term storage.
Which solvent should be used to reconstitute GHK-Cu 100mg?
GHK-Cu reconstitutes readily in sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Avoid chelating agents such as EDTA.
What endotoxin threshold does PX1 Research maintain for GHK-Cu?
PX1 Research enforces strict endotoxin limits (<0.01 EU/mg) using chromogenic LAL assays to ensure compatibility with sensitive cell cultures.
Where are PX1 Research peptides manufactured and dispatched from?
All compounds are manufactured in USA-based GMP-compliant facilities and shipped directly from fulfillment centers in California and Arizona.
Can institutions purchase GHK-Cu 100mg in bulk?
Yes, academic and industrial laboratories can set up dedicated institutional accounts through our wholesale portal for volume discounts and custom production runs.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.